Depreciation in USD of ATOSSA THERAPEUTICS, INC. from 2011 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
ATOSSA THERAPEUTICS, INC. quarterly/annual Depreciation history and change rate from 2011 to Q1 2025.
  • ATOSSA THERAPEUTICS, INC. Depreciation for the quarter ending 31 Mar 2025 was $4K, a 20% decline year-over-year.
  • ATOSSA THERAPEUTICS, INC. annual Depreciation for 2024 was $17K, a 26.1% decline from 2023.
  • ATOSSA THERAPEUTICS, INC. annual Depreciation for 2023 was $23K, a 188% increase from 2022.
  • ATOSSA THERAPEUTICS, INC. annual Depreciation for 2022 was $8K, a 20% decline from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

ATOSSA THERAPEUTICS, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $4K -$1K -20% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025
Q1 2024 $5K +$2K +66.7% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025
Q1 2023 $3K 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q1 2018 $19K $2.73K -$6.94K -71.8% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2018
Q4 2017 $26K $2.97K -$33.6K -91.9% 01 Oct 2017 31 Dec 2017 10-K 28 Mar 2019
Q3 2017 $59.6K $4.55K -$25.1K -84.7% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2017
Q2 2017 $84.7K $8.77K -$24K -73.2% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2017
Q1 2017 $109K $9.66K -$17K -63.7% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018
Q4 2016 $126K $36.6K +$22.7K +163% 01 Oct 2016 31 Dec 2016 10-K 08 Mar 2018
Q3 2016 $103K $29.7K -$2.92K -8.96% 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017
Q2 2016 $106K $32.7K +$19.5K +147% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 $86.4K $26.6K +$13.3K +100% 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017
Q4 2015 $73.1K $13.9K -$65.3K -82.4% 01 Oct 2015 31 Dec 2015 10-K/A 21 Mar 2017
Q3 2015 $138K $32.6K +$7.98K +32.4% 01 Jul 2015 30 Sep 2015 10-Q/A 21 Mar 2017
Q2 2015 $130K $13.3K -$6.59K -33.2% 01 Apr 2015 30 Jun 2015 10-Q/A 21 Mar 2017
Q1 2015 $137K $13.3K -$7.89K -37.3% 01 Jan 2015 31 Mar 2015 10-Q/A 21 Mar 2017
Q4 2014 $145K $79.2K +$59K +291% 01 Oct 2014 31 Dec 2014 10-K 30 Mar 2015
Q3 2014 $85.9K $24.6K -$2.52K -9.28% 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2014
Q2 2014 $88.5K $19.9K -$10.8K -35.2% 01 Apr 2014 30 Jun 2014 10-Q 12 Aug 2014
Q1 2014 $99.3K $21.2K +$16.3K +335% 01 Jan 2014 31 Mar 2014 10-Q 13 May 2015
Q4 2013 $83K $20.3K 01 Oct 2013 31 Dec 2013 10-K 30 Mar 2015
Q3 2013 $27.2K 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2014
Q2 2013 $30.7K 01 Apr 2013 30 Jun 2013 10-Q 12 Aug 2014
Q1 2013 $4.87K +$546 +12.6% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014
Q1 2012 $4.32K 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013

ATOSSA THERAPEUTICS, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $17K -$6K -26.1% 01 Jan 2024 31 Dec 2024 10-K 25 Mar 2025
2023 $23K +$15K +188% 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025
2022 $8K -$2K -20% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024
2021 $10K -$9K -47.4% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2022
2020 $19K -$3K -13.6% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2022
2019 $22K +$8K +57.1% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021
2018 $14K -$12K -46.1% 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2020
2017 $26K -$99.7K -79.3% 01 Jan 2017 31 Dec 2017 10-K 28 Mar 2019
2016 $126K +$52.6K +71.9% 01 Jan 2016 31 Dec 2016 10-K 08 Mar 2018
2015 $73.1K -$71.8K -49.6% 01 Jan 2015 31 Dec 2015 10-K/A 21 Mar 2017
2014 $145K +$61.9K +74.6% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2015
2013 $83K +$57.9K +231% 01 Jan 2013 31 Dec 2013 10-K 30 Mar 2015
2012 $25.1K +$21.2K +540% 01 Jan 2012 31 Dec 2012 10-K 27 Mar 2014
2011 $3.92K 01 Jan 2011 31 Dec 2011 10-K 28 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.